Unveiling novel targets in melanoma under melanogenesis stimulation and photodynamic therapy by redox proteomics

Abstract

AbstractMelanogenesis‐stimulated B16‐F10 cells enter in a quiescent state, present inhibited mitochondrial respiration and increased reactive oxygen species levels. These alterations suggest that these cells may be under redox signaling, allowing tumor survival. The aim of this study was to evaluate redox‐modified proteins in B16‐F10 cells after melanogenesis stimulation and rose bengal‐photodynamic therapy (RB‐PDT). A redox proteomics label‐free approach based on the biotin switch assay technique with biotin‐HPDP and N‐ethylmaleimide was used to assess the thiol‐oxidized protein profile. Aconitase was oxidized at Cys‐448 and Cys‐451, citrate synthase was oxidized at Cys‐202 and aspartate aminotransferase (Got2) was oxidized at Cys‐272 and Cys‐274, exclusively after melanogenesis stimulation. After RB‐PDT, only guanine nucleotide‐binding protein subunit beta‐2‐like 1 (Gnb2l1) was oxidized (Cys‐168). In contrast, melanogenesis stimulation followed by RB‐PDT led to the oxidation of different cysteines in Gnb2l1 (Cys‐153 and Cys‐249). Besides that, glyceraldehyde‐3‐phosphate dehydrogenase (Gapdh) presented oxidation at Cys‐245, peptidyl‐prolyl cis‐trans isomerase A (Ppia) was oxidized at Cys‐161 and 5,6‐dihydroxyindole‐2‐carboxylic acid oxidase (Tyrp1) was oxidized at Cys‐65, Cys‐30, and Cys‐336 after melanogenesis stimulation followed by RB‐PDT. The redox alterations observed in murine melanoma cells and identification of possible target proteins are of great importance to further understand tumor resistance mechanisms.